- Supported exchanges /
- SHE /
- 300255.SHE
Hebei Changshan Biochem Pharma (300255 SHE) stock market data APIs
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of crude heparin, heparin raw materials, and heparin preparations for the treatment of cardiovascular and cerebrovascular diseases in China and internationally. It offers crude heparin sodium, heparin sodium raw materials, heparin sodium injections, low molecular weight heparin calcium raw materials and injections, enoxaparin sodium raw materials and injections, nadri heparin calcium API, nandroparin calcium injection, and dalteparin sodium API and injection. The company was founded in 2000 and is based in Shijiazhuang, China.
Hebei Changshan Biochem Pharma Financial Data Overview
| 18.95 | |
| 20.71 | |
| - | |
| 20.95 | |
| 18.95 | |
| 7.56-25.88 | |
| 17 416 M | |
| 919 M | |
| 1 055 M | |
| 0.059 | |
| 0.046 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Hebei Changshan Biochem Pharma Fundamental Data is available in our Financial Data APIs
- Net Revenue 1 055 M
- EBITDA -854 456 960
- Earnings Per Share -0.92
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Hebei Changshan Biochem Pharma Earnings via APIs
- Latest Release 2024-10-30
- EPS/Forecast NaN
Get Hebei Changshan Biochem Pharma End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
